✦ LIBER ✦

Phase II trial of gemcitabine and paclitaxel (GEMTAX) combination in recurrent or advanced squamous cell carcinoma of the head and neck

✍ Scribed by O. Kucuk; J. Fontana; J. Ensley

Book ID: 117658251
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 164 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80882-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of oxaliplatin (L-OHP) in

Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck

✍ M. Degardin; P. Cappelaere; I. Krakowski; P. Fargeot; D. Cupissol; S. Brienza 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Induction paclitaxel in previously untre

Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck : A Phase II trial

✍ John C. Grecula; Roy E. Smith; Chris A. Rhoades; Pramod Sharma; Amit Agrawal; Ho 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 3 views

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase II trial of carboplatin and vinbla

Phase II trial of carboplatin and vinblastine in advanced squamous-cell carcinoma of the head and neck

✍ S. EL Sayed; R. P. Symonds; A. G. Robertson; J. Paul; J. McGarva 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 217 KB

Phase 2 Trial of AT-101 in Combination W

Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC)

✍ Sacco, A.; Nor, J.; Belile, E.; Sukari, A.; Chepeha, D.; Bradford, C.; Eisbruch, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi